Celldex Therapeutics, Inc.
CLDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $23 | $17 | $28 |
| Short-Term Investments | $547 | $607 | $656 | $697 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $21 | $18 | $19 | $21 |
| Total Curr. Assets | $604 | $648 | $694 | $747 |
| Property Plant & Equip (Net) | $8 | $8 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $27 | $27 | $27 | $27 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $9 | $10 | $10 |
| Total NC Assets | $44 | $44 | $46 | $45 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $648 | $692 | $739 | $792 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $3 | $3 |
| Short-Term Debt | $2 | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $41 | $29 | $27 | $35 |
| Total Curr. Liab. | $46 | $33 | $32 | $40 |
| LT Debt | $1 | $1 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $3 | $3 | $3 |
| Total NC Liab. | $4 | $4 | $4 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $4 |
| Total Liabilities | $50 | $37 | $36 | $45 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,733 | -$1,666 | -$1,609 | -$1,555 |
| AOCI | $4 | $3 | $4 | $3 |
| Other Equity | $2,327 | $2,318 | $2,308 | $2,299 |
| Total Equity | $598 | $655 | $703 | $747 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $648 | $692 | $739 | $792 |
| Net Debt | -$33 | -$20 | -$14 | -$25 |